| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/10/2008 | US20080009454 Polynucleotide |
| 01/10/2008 | US20080009444 Biologically active complex of NR6 and cardiotrophin-like-cytokine |
| 01/10/2008 | US20080009440 Soothing Agent and Food for Treating Fatigue |
| 01/10/2008 | US20080009439 Compositions and Methods of Use for a Fibroblast Growth Factor |
| 01/10/2008 | US20080008776 Natural Extract Containing Xanthohumol, and Method for the Production Thereof Products Produced Therefrom |
| 01/10/2008 | US20080008774 Use Of Plants, Plant Extracts And Nature-Identical Components From Plants To Affect The Rumen Fermentation And To Improve The Energy And Protein Retention Of Ruminants |
| 01/10/2008 | US20080008773 Food beverage or feed for the promotion of osteogenesis comprising umbelliferae, liliaceae or compositae plant species |
| 01/10/2008 | US20080008764 Carbon-substituted diketopiperazine delivery systems |
| 01/10/2008 | US20080008754 Pharmaceutical Compositions Comprising (+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-Trimethyl-2-Morpholinol |
| 01/10/2008 | US20080008753 Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof |
| 01/10/2008 | US20080008743 Orally Dissolving Formulations of Memantine |
| 01/10/2008 | US20080008740 Pharmaceutical Composition for Rectal, or Vaginal Application, Method of Manufacturing and Use as Medicament Thereof |
| 01/10/2008 | US20080008726 Vaccine Composition Against Rhodococcus Equi |
| 01/10/2008 | US20080008724 Expanding the T cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails |
| 01/10/2008 | US20080008714 TWEAK receptor agonists as anti-angiogenic agents |
| 01/10/2008 | US20080008710 Therapeutic Agent And Diagnostic Agent For Cholangiocarcinoma |
| 01/10/2008 | US20080008707 Denatured collagen peptides and uses thereof |
| 01/10/2008 | US20080008705 Cancer prognostic diagnostic and treatment methods |
| 01/10/2008 | US20080008700 Multimeric Fc Receptor Polypeptides |
| 01/10/2008 | US20080008699 Method for proteomic analysis utilizing immune recognition and cumulative subtraction |
| 01/10/2008 | US20080008691 Modified growth hormone |
| 01/10/2008 | US20080008687 Transposon-Based Targeting System |
| 01/10/2008 | US20080008656 Agent for enhancing contrast of image of fluorescent staining of lumen of digestive tract |
| 01/10/2008 | US20080008653 Models for vaccine assessment |
| 01/10/2008 | US20080007840 Optical apparatus and methods for chemical analysis |
| 01/10/2008 | CA2660182A1 Dioxo-alkanes and dioxo-alkenes compounds |
| 01/10/2008 | CA2656959A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | CA2656851A1 Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity |
| 01/10/2008 | CA2656183A1 Modulators of muscarinic receptors |
| 01/10/2008 | CA2654666A1 Pharmaceutical compositions |
| 01/10/2008 | CA2650433A1 Method of treatment of hereditary hemochromatosis |
| 01/09/2008 | EP1876186A1 Prophylactic/therapeutic agent for cancer |
| 01/09/2008 | EP1876179A1 Thienopyrimidone compound |
| 01/09/2008 | EP1876178A1 Cyanopyridine derivative and use thereof as medicine |
| 01/09/2008 | EP1876173A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors |
| 01/09/2008 | EP1876167A1 Crystal polymorphism of 4 -{2-ý(1s,2r)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethylamino¨ethoxy}-3-isopropyl-3 ,5 -dimethylbiphenylcarboxylic acid hydrochloride |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1874316A1 Use of pde-5 inhibitors for endothelial repair of tissues impaired by trauma or disease |
| 01/09/2008 | EP1527068B1 Novel arylimidazole derivatives, their use as no-syntase inhibitors and as modulators of sodium channels |
| 01/09/2008 | EP1527048B1 N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, preparation thereof, and use thereof in therapy |
| 01/09/2008 | EP1490053B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 01/09/2008 | EP1465922B1 Corticotropin releasing factor receptor 2 agonists |
| 01/09/2008 | EP1460084B1 Novel peptide sy |
| 01/09/2008 | EP1446118B1 Oral dosage form of parecoxib |
| 01/09/2008 | EP1402890B1 Sulfonamide derivatives |
| 01/09/2008 | EP1400513B1 Unsymmetrical cyclic diamine compound |
| 01/09/2008 | EP1385845B1 N-aroyl cyclic amines |
| 01/09/2008 | EP1373218B1 Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 01/09/2008 | EP1324766B1 Fgf-2 for the treatment of peripheral artery disease |
| 01/09/2008 | EP1263730B1 Amine derivatives for the treatment of apoptosis |
| 01/09/2008 | EP1254176B1 Use of the extracellular domain of TRADE molecules in medicaments for treating neoplasia |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP1176956B1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | EP0814789B2 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/09/2008 | CN101103032A 双环吡咯衍生物 Bicyclopyrrole derivatives |
| 01/09/2008 | CN101102788A Fibrosis inhibitor for implanted organ |
| 01/09/2008 | CN101102744A Skin-whitening agent |
| 01/09/2008 | CN101100472A 4-amino-5,6-substituted thiopheno [2,3-D] pyrimidines compound and its uses |
| 01/09/2008 | CN101100453A Method for synthesizing ifenprodil tartrate |
| 01/09/2008 | CN101099761A Pueraria flavone anti-radiation, anti-fatigue, resisting oxygen deficit and heart protecting action |
| 01/09/2008 | CN101099757A Pearl kuding tea lozenge |
| 01/09/2008 | CN101099745A Methods and compositions for treating flaviviruses and pestiviruses |
| 01/09/2008 | CN101099725A Method for preparing composite substrate multifunctional arterial embolic agent |
| 01/09/2008 | CN101099520A Anti-acne health tea |
| 01/09/2008 | CN100360628C Adhesive |
| 01/09/2008 | CN100360564C Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 01/09/2008 | CN100360553C Compounds and use thereof to modify transport across cell membranes |
| 01/09/2008 | CN100360550C Liver X receptor agonists |
| 01/09/2008 | CN100360548C Oligosaccharide derivative |
| 01/09/2008 | CN100360538C Thienopyrimidine compound and use of the same |
| 01/09/2008 | CN100360534C Separation of regioisomers of metal phthalocyanines |
| 01/09/2008 | CN100360521C 4,4-disubstituted piperidine derivatives having CCR3 antagonism |
| 01/09/2008 | CN100360514C Novel, ascorbic acid compounds, methods of synthesis and application use thereof |
| 01/09/2008 | CN100360507C Inhibition of raf kinase using substituted heterocyclic ureas |
| 01/09/2008 | CN100360182C Induction of antigen specific immunologic tolerance |
| 01/09/2008 | CN100360181C Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 01/09/2008 | CN100360180C Use of copolymer 1 and related peptides and polypeptides and T cells treated therewith for neuroprotective therapy |
| 01/09/2008 | CN100360178C Antisenescence medicine |
| 01/09/2008 | CN100360156C Chinese medicine composition new use |
| 01/09/2008 | CN100360143C Use of Herba Artemisiae Vulgaris potato |
| 01/09/2008 | CN100360123C Methods and pharmaceutical compostions employing desmethylselegiline |
| 01/09/2008 | CN100360122C Preventive and/or therapeutic agent for viral infection |
| 01/09/2008 | CN100360121C Methods and compositions for preventing and treating chronological aging in human skin |
| 01/08/2008 | US7317114 Process to obtain dibenzylbutyrolactonic lignans, process to obtain synthetic derivatives from lignans bearing anti-Chagas chemoprophylactic and therapeutical activities |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317097 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 01/08/2008 | US7317096 Isolated or recombinant nucleic acid sequence encoding an (AAP-1), |
| 01/08/2008 | US7317085 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 01/08/2008 | US7317040 Nitric oxide synthase inhibitor phosphate salt |
| 01/08/2008 | US7317039 Deuterated substituted dihydrofuranones and medicaments containing these compounds |
| 01/08/2008 | US7317038 1,3-Diacetyl-8-hydroxy-2-(7-hydroxychromanon-3-yl)-9H-xanthen-9-ones; obtained from a culture of the Penicillium strain SPF-3059; prevents growth cone collapse |
| 01/08/2008 | US7317036 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7317014 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 01/08/2008 | US7317012 Bicyclic heterocycles as cannabinoind-1 receptor modulators |
| 01/08/2008 | US7317011 Method of treating peripheral neuropathy |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | US7316900 Comprises methylated antisense oligonucleotide sequence for regulation of urokinase type plasminogen activator and treatment of cancer |
| 01/08/2008 | US7316812 Cells expressing anti-Fc receptor binding components |